{"DataElement":{"publicId":"13362284","version":"1","preferredName":"Measurable Residual Disease Assessment Text","preferredDefinition":"A textual description of evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","longName":"13336628v1.00:2666625v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13336628","version":"1","preferredName":"Measurable Residual Disease Assessment","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.:The final result of a determination of the value, significance, or extent of.","longName":"2452232v1.00:2465182v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2452232","version":"1","preferredName":"Minimal Residual Disease","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","longName":"C3896","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7AD9-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F8FFB5C4-3EA1-18AF-E053-731AD00AAFBF","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-10","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":"4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2666625","version":"1","preferredName":"40 Character Text","preferredDefinition":"A number with no fractional part.::40_An expression consisting of a linear sequence of symbols (characters or words or phrases)._An expression consisting of a linear sequence of symbols (characters or words or phrases).","longName":"2666625v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"0","maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2666624","version":"1","preferredName":"Integer::40 String Text","preferredDefinition":"A number with no fractional part.::40:An expression consisting of a linear sequence of symbols (characters or words or phrases).:Text; the words of something written.","longName":"C45255::40:C45253:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"String","conceptCode":"C45253","definition":"An expression consisting of a linear sequence of symbols (characters or words or phrases).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35B7CB52-55B1-743D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-07-20","modifiedBy":"SBR","dateModified":"2007-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"35B7CB52-55C2-743D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-07-20","modifiedBy":"CHILLIJ","dateModified":"2008-12-15","changeDescription":"12/15/08 - released for use in C3D MGH Imaging trial.  7/08 - created to support ACRIN Breast CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173180","version":"1","longName":"Response","context":"Pediatric Cancer"},{"publicId":"12173217","version":"1","longName":"Minimal Residual Disease","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"MRD_RESULT","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"MRD Result","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F953EA85-642D-07F7-E053-731AD00A3D46","latestVersionIndicator":"Yes","beginDate":"2023-04-14","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-14","modifiedBy":"SOKKERL","dateModified":"2023-05-09","changeDescription":null,"administrativeNotes":"4/14/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}